AstraZeneca Plc on Thursday signed a deal with a China-based company for producing its potential drug to treat novel coronavirus in mainland China. Shenzhen Kangtai Biological Products becomes the first Chinese company to enter into a deal with AstraZeneca.

AstraZeneca signs first deal with Chinese firm to produce COVID-19 vaccine

astrazeneca-pharma-india-ltd

Astrazeneca Pharma India Ltd, News on Astrazeneca Pharma India Ltd, stories on Astrazeneca Pharma India Ltd, articles on Astrazeneca Pharma India Ltd, Astrazeneca Pharma India Ltd stories at Wion, Astrazeneca Pharma India Ltd news, Astrazeneca Pharma India Ltd latest news

astrazeneca pharma-india-ltd

AstraZeneca signs first deal with Chinese firm to produce COVID-19 vaccine